Seeing Is Believing
Currently out of the existing stock ratings of Serge Belanger, 278 are a BUY (95.21%), 14 are a HOLD (4.79%).
Analyst Serge Belanger works at NEEDHAM with a stock forecast success ratio of 26.56% fulfilled within 177.47 days on average.
Serge Belanger’s has documented 567 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KALV, Kalvista Pharmaceuticals at 01-May-2024.
Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for KALV (KALVISTA PHARMACEUTICALS) at 1/26/2021. The price target of $32 was fulfilled within 14 days with a profit of $15.65 (95.72%) receiving and performance score of 68.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
71
$28.92 (68.73%)
41
8 months 23 days ago
10/11 (90.91%)
$8.79 (14.13%)
337
Buy
70
$27.92 (66.35%)
44
9 months 7 days ago
2/3 (66.67%)
$8.35 (13.54%)
105
Hold
44
$1.92 (4.56%)
40
11 months 15 days ago
5/5 (100%)
$1.03 (2.40%)
86
Buy
33
$-25.16 (-43.26%)
24
2 years 1 months 21 days ago
3/3 (100%)
$-1.3 (-3.79%)
375
Hold
3 years 9 months 23 days ago
2/2 (100%)
$5.8 (47.54%)
224
Which stock is Serge Belanger is most bullish on?
Which stock is Serge Belanger is most reserved on?
What Year was the first public recommendation made by Serge Belanger?